Page last updated: 2024-09-04

risarestat and fluorescein

risarestat has been researched along with fluorescein in 1 studies

Compound Research Comparison

Studies (risarestat)	Trials (risarestat)	Recent Studies (post-2010) (risarestat)	Studies (fluorescein)	Trials (fluorescein)	Recent Studies (post-2010) (fluorescein)
29	4	9	6,214	283	2,082

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Amano, S; Miyai, T; Miyata, K; Nakahara, M; Nejima, R; Otani, S; Yamagami, S	1

Trials

1 trial(s) available for risarestat and fluorescein

Article	Year
A randomised, placebo controlled clinical trial of the aldose reductase inhibitor CT-112 as management of corneal epithelial disorders in diabetic patients. The British journal of ophthalmology, 2005, Volume: 89, Issue:3 Topics: Aged; Aldehyde Reductase; Corneal Ulcer; Diabetes Mellitus; Double-Blind Method; Epithelium, Corneal; Fluorescein; Fluorophotometry; Humans; Middle Aged; Ophthalmic Solutions; Permeability; Prospective Studies; Sensory Thresholds; Statistics, Nonparametric; Thiazolidinediones; Time Factors	2005

Article

Year

A randomised, placebo controlled clinical trial of the aldose reductase inhibitor CT-112 as management of corneal epithelial disorders in diabetic patients.

The British journal of ophthalmology, 2005, Volume: 89, Issue:3

Topics: Aged; Aldehyde Reductase; Corneal Ulcer; Diabetes Mellitus; Double-Blind Method; Epithelium, Corneal; Fluorescein; Fluorophotometry; Humans; Middle Aged; Ophthalmic Solutions; Permeability; Prospective Studies; Sensory Thresholds; Statistics, Nonparametric; Thiazolidinediones; Time Factors

2005